GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BDH Industries Ltd (BOM:524828) » Definitions » Net Current Asset Value

BDH Industries (BOM:524828) Net Current Asset Value : ₹0.00 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is BDH Industries Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

BDH Industries's net current asset value per share for the quarter that ended in Dec. 2023 was ₹0.00.

The historical rank and industry rank for BDH Industries's Net Current Asset Value or its related term are showing as below:

BOM:524828' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.36   Med: 2.83   Max: 7.16
Current: 5.28

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of BDH Industries was 7.16. The lowest was 1.36. And the median was 2.83.

BOM:524828's Price-to-Net-Current-Asset-Value is ranked better than
52.83% of 600 companies
in the Drug Manufacturers industry
Industry Median: 5.595 vs BOM:524828: 5.28

BDH Industries Net Current Asset Value Historical Data

The historical data trend for BDH Industries's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BDH Industries Net Current Asset Value Chart

BDH Industries Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.18 29.62 39.45 49.98 61.05

BDH Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 61.05 - 64.66 -

Competitive Comparison of BDH Industries's Net Current Asset Value

For the Drug Manufacturers - Specialty & Generic subindustry, BDH Industries's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BDH Industries's Price-to-Net-Current-Asset-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BDH Industries's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where BDH Industries's Price-to-Net-Current-Asset-Value falls into.



BDH Industries Net Current Asset Value Calculation

BDH Industries's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Mar. 2023 is calculated as

Net Current Asset Value Per Share(A: Mar. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(604.818-253.315-0-0)/5.7573
=61.05

BDH Industries's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0-N/A-0-0)/5.7573
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BDH Industries  (BOM:524828) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


BDH Industries Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of BDH Industries's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BDH Industries (BOM:524828) Business Description

Traded in Other Exchanges
N/A
Address
Nair Baug, Akurli Road, Kandivli (East), Mumbai, MH, IND, 400101
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The Company has one reportable segment which is pharmaceuticals. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others. It manufactures Sildenafil Citrate Tablets, Bulk Drugs and Others.

BDH Industries (BOM:524828) Headlines

No Headlines